Sarah Cannon Research Institute
Cody Sanders has extensive experience in financial planning and analysis, having worked at Sarah Cannon Research Institute since July 2011, progressing from Staff Accountant I to Manager, Financial Planning and Analysis. Prior roles include Senior Financial Analyst, Financial Analyst, Senior Accountant, and Data Integrity Analyst/Billing Specialist. Prior to this, Cody Sanders gained experience as a Finance/Accounting Intern at Matrix Integration in 2010. Education includes a Bachelor of Science in Business, with a focus on Finance and Operations Management, from Indiana University - Kelley School of Business, completed in 2011.
This person is not in any offices
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.